From 1991 to 2015, the cancer death rate dropped about 1.5 percent a year, resulting in a total decrease of 26 percent — 2,378,600 fewer deaths than would have occurred had the rate remained at its peak. Read more here.
No area is hotter or attracting more dollars in pharma than immuno-oncology–the idea of harnessing the immune system to fight cancer. Read more here.
Derek Laurie was working as a tow truck driver, living in a suburb outside Rochester, New York, and supporting two small children. It was tough work. Read more here.
Vice President Biden, who led the Obama administration’s “cancer moonshot” initiative, will create a nonprofit organization to grapple with a broad range of cancer issues, including the high cost of cancer drugs, he said in an interview Wednesday. Read more here.
IN THE pharma business, Juno Therapeutics, a small firm based in Seattle, is just a stripling. It is three years old, has not a single drug approval to its name but is nonetheless valued at $2.8 billion. That value is derived from the fact that it is on the forefront of the most promising area […]
I recently chronicled the story of Jason Greenstein and his battle against cancer. He was at the vanguard of a new kind of treatment that unleashes the immune system to fight the disease as it does infections caused by viruses and bacteria. But his reprieve lasted just over a year. Jason died last week, leaving […]
U.S. Vice President Joseph Biden on Friday announced new measures to help cancer patients navigate the clinical trials process as part of the administration’s “Cancer Moonshot” initiative to speed new treatments to market. In a statement released ahead of a planned speech at Rice University in Houston, Biden said clinical trials are essential for developing […]
By MATT JABLOW TOWSON, Md. — Two days into a long-dreamed-of family vacation to Italy in August 2013, my wife, Ronna, became nauseated, unusually tired and short of breath. One of the great non-complainers in American history, she insisted that it was no big deal and valiantly tried to join in on various outings in […]
Vice President Biden speaks at the Cancer Moonshot Summit at Howard University in Washington on Wednesday. (Carolyn Kaster/AP) Biden threatens funding cuts for researchers who don’t report clinical-trial data An impatient Vice President Biden threatened Wednesday to cut funding to research facilities that fail to report clinical-trial results quickly enough and took a swipe at […]
Trial Medication Treatment By Barack Obama JULY 07, 2016 HEALTH CARE is always personal. As science and technology have advanced, it’s become possible to make it personalized as well, giving us the tools to better understand, prevent, and treat everyone’s individual health needs. We wouldn’t buy a pair of glasses that doesn’t match our […]
Elaine Schattner, CONTRIBUTOR Of all the reports being presented at this year’s big cancer meeting, the one I think most important is not about a particular drug or malignancy. It’s about the design of clinical trials. For cancer patients trying an experimental drug, participating in a “matched” study–using biomarkers, like genetics, to link their condition […]
Doctors have taken an important step toward a long-sought goal: harnessing a person’s own immune system to fight cancer. Read more here.
The Food and Drug Administration approved a second version of a groundbreaking treatment Wednesday that genetically alters patients’ cells to attack cancer — this time, to fight aggressive non-Hodgkin lymphoma. Read more here.
Over the summer of 2011, the water in Lake Michigan turned crystal clear. Read more here.
Ever since scientists began decoding the human genome in 1990, doctors have predicted an age of “precision medicine” where patients are matched with drugs that target the specific genetic drivers of their disease. Read more here.
Cancer researcher Jim Allison stands at the edge of a small stage, fiddling with his harmonica, his unruly gray hair hanging almost to his shoulders. Read more here.
Flatiron Health focuses on helping community oncologists because they still care for the majority of patients with cancer and make it possible for patients to get care without traveling long distances, explained Nat Turner, co-founder and CEO of Flatiron Health. Watch video here.
Tumor-destroying vaccines have emerged as a new weapon in the fight against cancer. Read more here.
In 2010, 5-year-old Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL). Read more here.
The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments. Read more here.
By searching the church’s famed family trees, scientists have tracked down a cancer-causing mutation that came west with a pioneer couple—just in time to save the lives of their great-great-great-great grandchildren. Read more here.